Literature DB >> 28205498

Cognitive Control, Learning, and Clinical Motor Ratings Are Most Highly Associated with Basal Ganglia Brain Volumes in the Premanifest Huntington's Disease Phenotype.

Maria B Misiura1, Spencer Lourens2, Vince D Calhoun3, Jeffrey Long2, Jeremy Bockholt2, Hans Johnson2, Ying Zhang2, Jane S Paulsen2, Jessica A Turner1, Jingyu Liu3, Betul Kara4, Elizabeth Fall1.   

Abstract

OBJECTIVES: Huntington's disease (HD) is a debilitating genetic disorder characterized by motor, cognitive and psychiatric abnormalities associated with neuropathological decline. HD pathology is the result of an extended chain of CAG (cytosine, adenine, guanine) trinucleotide repetitions in the HTT gene. Clinical diagnosis of HD requires the presence of an otherwise unexplained extrapyramidal movement disorder in a participant at risk for HD. Over the past 15 years, evidence has shown that cognitive, psychiatric, and subtle motor dysfunction is evident decades before traditional motor diagnosis. This study examines the relationships among subcortical brain volumes and measures of emerging disease phenotype in prodromal HD, before clinical diagnosis.
METHODS: The dataset includes 34 cognitive, motor, psychiatric, and functional variables and five subcortical brain volumes from 984 prodromal HD individuals enrolled in the PREDICT HD study. Using cluster analyses, seven distinct clusters encompassing cognitive, motor, psychiatric, and functional domains were identified. Individual cluster scores were then regressed against the subcortical brain volumetric measurements.
RESULTS: Accounting for site and genetic burden (the interaction of age and CAG repeat length) smaller caudate and putamen volumes were related to clusters reflecting motor symptom severity, cognitive control, and verbal learning.
CONCLUSIONS: Variable reduction of the HD phenotype using cluster analysis revealed biologically related domains of HD and are suitable for future research with this population. Our cognitive control cluster scores show sensitivity to changes in basal ganglia both within and outside the striatum that may not be captured by examining only motor scores. (JINS, 2017, 23, 159-170).

Entities:  

Keywords:  Basal ganglia; Caudate; Cluster analysis; Clustering; Cognition; Cognitive control; Neuropsychology; Prodromal Huntington’s disease; Psychiatric symptoms; Striatum

Mesh:

Substances:

Year:  2017        PMID: 28205498      PMCID: PMC5803794          DOI: 10.1017/S1355617716001132

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  57 in total

1.  Longitudinal Psychiatric Symptoms in Prodromal Huntington's Disease: A Decade of Data.

Authors:  Eric A Epping; Ji-In Kim; David Craufurd; Thomas M Brashers-Krug; Karen E Anderson; Elizabeth McCusker; Jolene Luther; Jeffrey D Long; Jane S Paulsen
Journal:  Am J Psychiatry       Date:  2015-10-16       Impact factor: 18.112

2.  Impaired cortico-striatal functional connectivity in prodromal Huntington's Disease.

Authors:  Paul G Unschuld; Suresh E Joel; Xinyang Liu; Megan Shanahan; Russell L Margolis; Kevin M Biglan; Susan S Bassett; David J Schretlen; Graham W Redgrave; Peter C M van Zijl; James J Pekar; Christopher A Ross
Journal:  Neurosci Lett       Date:  2012-03-07       Impact factor: 3.046

3.  Striatal metabolism and psychomotor speed as predictors of motor onset in Huntington's disease.

Authors:  Meike Herben-Dekker; Joost C H van Oostrom; Raymund A C Roos; Caroline K Jurgens; Marie-Noëlle W Witjes-Ané; Hubertus P H Kremer; Klaus L Leenders; Jacoba M Spikman
Journal:  J Neurol       Date:  2014-04-30       Impact factor: 4.849

4.  Characterization of depression in prodromal Huntington disease in the neurobiological predictors of HD (PREDICT-HD) study.

Authors:  Eric A Epping; James A Mills; Leigh J Beglinger; Jess G Fiedorowicz; David Craufurd; Megan M Smith; Mark Groves; Kelly R Bijanki; Nancy Downing; Janet K Williams; Jeffrey D Long; Jane S Paulsen
Journal:  J Psychiatr Res       Date:  2013-06-19       Impact factor: 4.791

5.  Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's Disease.

Authors:  Saul Martinez-Horta; Jesus Perez-Perez; Erik van Duijn; Ramon Fernandez-Bobadilla; Mar Carceller; Javier Pagonabarraga; Berta Pascual-Sedano; Antonia Campolongo; Jesus Ruiz-Idiago; Frederic Sampedro; G Bernhard Landwehrmeyer; Jaime Kulisevsky
Journal:  Parkinsonism Relat Disord       Date:  2016-02-11       Impact factor: 4.891

Review 6.  Huntington's disease: from molecular pathogenesis to clinical treatment.

Authors:  Christopher A Ross; Sarah J Tabrizi
Journal:  Lancet Neurol       Date:  2011-01       Impact factor: 44.182

7.  Variation of selective gray and white matter atrophy in Huntington's disease.

Authors:  Robert Jech; Jirí Klempír; Josef Vymazal; Jana Zidovská; Olga Klempírová; Evzen Růzicka; Jan Roth
Journal:  Mov Disord       Date:  2007-09-15       Impact factor: 10.338

8.  Regional specificity of brain atrophy in Huntington's disease.

Authors:  G M Halliday; D A McRitchie; V Macdonald; K L Double; R J Trent; E McCusker
Journal:  Exp Neurol       Date:  1998-12       Impact factor: 5.330

Review 9.  Apathy: a neuropsychiatric syndrome.

Authors:  R S Marin
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1991       Impact factor: 2.198

10.  Feasibility of multi-site clinical structural neuroimaging studies of aging using legacy data.

Authors:  Christine Fennema-Notestine; Anthony C Gamst; Brian T Quinn; Jenni Pacheco; Terry L Jernigan; Leon Thal; Randy Buckner; Ron Killiany; Deborah Blacker; Anders M Dale; Bruce Fischl; Brad Dickerson; Randy L Gollub
Journal:  Neuroinformatics       Date:  2007-11-13
View more
  9 in total

1.  Regional subcortical shape analysis in premanifest Huntington's disease.

Authors:  Xiaoying Tang; Christopher A Ross; Hans Johnson; Jane S Paulsen; Laurent Younes; Roger L Albin; J Tilak Ratnanather; Michael I Miller
Journal:  Hum Brain Mapp       Date:  2018-10-30       Impact factor: 5.038

2.  Whole-Brain Connectivity in a Large Study of Huntington's Disease Gene Mutation Carriers and Healthy Controls.

Authors:  Flor A Espinoza; Jessica A Turner; Victor M Vergara; Robyn L Miller; Eva Mennigen; Jingyu Liu; Maria B Misiura; Jennifer Ciarochi; Hans J Johnson; Jeffrey D Long; Henry J Bockholt; Vincent A Magnotta; Jane S Paulsen; Vince D Calhoun
Journal:  Brain Connect       Date:  2018-03-08

3.  Dynamic functional network connectivity in Huntington's disease and its associations with motor and cognitive measures.

Authors:  Flor A Espinoza; Jingyu Liu; Jennifer Ciarochi; Jessica A Turner; Victor M Vergara; Arvind Caprihan; Maria Misiura; Hans J Johnson; Jeffrey D Long; Jeremy H Bockholt; Jane S Paulsen; Vince D Calhoun
Journal:  Hum Brain Mapp       Date:  2019-01-07       Impact factor: 5.038

4.  svReg: Structural varying-coefficient regression to differentiate how regional brain atrophy affects motor impairment for Huntington disease severity groups.

Authors:  Rakheon Kim; Samuel Müller; Tanya P Garcia
Journal:  Biom J       Date:  2021-04-19       Impact factor: 1.715

5.  Cognitive Dysfunction Contributes to Mobility Impairments in Huntington's Disease.

Authors:  Anne D Kloos; Deb A Kegelmeyer; Nora E Fritz; Allison M Daley; Gregory S Young; Sandra K Kostyk
Journal:  J Huntingtons Dis       Date:  2017

6.  Genetics Modulate Gray Matter Variation Beyond Disease Burden in Prodromal Huntington's Disease.

Authors:  Jingyu Liu; Jennifer Ciarochi; Vince D Calhoun; Jane S Paulsen; H Jeremy Bockholt; Hans J Johnson; Jeffrey D Long; Dongdong Lin; Flor A Espinoza; Maria B Misiura; Arvind Caprihan; Jessica A Turner
Journal:  Front Neurol       Date:  2018-03-29       Impact factor: 4.003

7.  Structural neuroimaging differentiates vulnerability from disease manifestation in colombian families with Huntington's disease.

Authors:  Maria Del C Valdés Hernández; Janna Abu-Hussain; Xinyi Qiu; Josef Priller; Mario Parra Rodríguez; Mariana Pino; Sandra Báez; Agustín Ibáñez
Journal:  Brain Behav       Date:  2019-07-05       Impact factor: 2.708

8.  A novel rhesus macaque model of Huntington's disease recapitulates key neuropathological changes along with motor and cognitive decline.

Authors:  Alison R Weiss; William A Liguore; Kristin Brandon; Xiaojie Wang; Zheng Liu; Jacqueline S Domire; Dana Button; Sathya Srinivasan; Christopher D Kroenke; Jodi L McBride
Journal:  Elife       Date:  2022-10-07       Impact factor: 8.713

9.  Apathy Is Related to Cognitive Control and Striatum Volumes in Prodromal Huntington's Disease.

Authors:  Maria B Misiura; Jennifer Ciarochi; Jatin Vaidya; Jeremy Bockholt; Hans J Johnson; Vince D Calhoun; Jane S Paulsen; Jessica A Turner
Journal:  J Int Neuropsychol Soc       Date:  2019-02-26       Impact factor: 2.892

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.